Exogenus distinguished at Merck Venture Lounge

Exogenus was distinguished as one of the most innovative Life Sciences & Medtech projects in Europe at Merck Venture Lounge, 2017!

The Venture Lounge is an initiative of EASME through SME Instrument Phase 3 services. https://ec.europa.eu/easme/en/news/pitching-contest-merck-venture-lounge-and-sme-instrument-starts-today

Joana Correia on this award: “For a startup it’s really important to have the recognition of relevant industry players, special on a industry with high market barriers such as pharma. We will continue seeking startegic partnerships for the development and commercialization of our clinical applications. Being a beneficiary of SME Instrument and a Seal of Excellence owner has been instrumental in presenting amazing opportunities to showcase our company and products, such as access to SME instrument Phase 3 services.”

Merck Venture Lounge winner